Clinical Trials Logo

Filter by:
NCT ID: NCT06219434 Recruiting - Breast Carcinoma Clinical Trials

Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer

Start date: November 13, 2023
Phase: N/A
Study type: Interventional

This clinical trial tests how well a mindfulness intervention helps the prevention of chemotherapy-brain (chemo-brain) in women preparing for chemotherapy for breast cancer. Cognitive dysfunction after chemotherapy has been well-documented. Factors that have been used to document and/or have been correlated with chemo brain include self-report and structural brain changes including volume loss. Mindfulness is a type of meditation practice that can be learned to support well-being and decrease stress. Mindfulness is an approach that helps the person increase their awareness of the present moment without judgement. There are data that mindfulness may increase attention and concentration which may prevent some of the side effects from chemotherapy

NCT ID: NCT06219408 Not yet recruiting - Chronic Pain Clinical Trials

Integrating Mind-Body Practices Into Primary Care Treatment

Start date: June 2, 2025
Phase: N/A
Study type: Interventional

The current study is a pilot RCT of a CIH stepped approach to care.

NCT ID: NCT06219278 Active, not recruiting - Wrinkle Clinical Trials

A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles

Start date: October 29, 2023
Phase: N/A
Study type: Interventional

This is a retrospective chart review of data from the multi-site prospective clinical trial, "Functional Usability and Feasibility Testing of the Profound Matrix™ System (FUFT2002)" to evaluate the safety and efficacy of the Profound Matrix System Matrix Pro applicator for the treatment of wrinkles.

NCT ID: NCT06219174 Recruiting - Lung Cancer Clinical Trials

Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)

Start date: December 18, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to establish the safety, toxicity, and tolerability of Difluoromethylornithine (DFMO) in combination with pembrolizumab in advanced/metastatic Non-Small Cell Lung Cancer (NSCLC). Researchers also want to investigate how effective DFMO is at treating patients with advanced/ metastatic NSCLC.

NCT ID: NCT06219161 Completed - Stem Cells Clinical Trials

The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations.

Start date: January 2, 2023
Phase: N/A
Study type: Interventional

The goal of the study is to determine the acute and short-term supplementation effect of a commercially available theacrine-containing supplement (NAD3) on numbers of various circulating stem cell populations in older adults.

NCT ID: NCT06219148 Recruiting - Dementia Clinical Trials

Music Therapy and Social Work Telehealth for Older Adult Well-Being

Melo-SWell
Start date: March 19, 2024
Phase: N/A
Study type: Interventional

This study investigates the benefits of using telehealth services, specifically a combination of music therapy and social work support, to improve the well-being of older adults. Investigators are focusing on outcomes such as reduced loneliness, improved cognition, and how well older adults with and without dementia perceive the quality of the services received. This research is crucial because as the population ages and conditions like Alzheimer's become more prevalent, effective psychosocial interventions are needed. The collaborative telehealth approach of the intervention in this study strives to connect older adults to community and health-related services. Older adults experience challenges in accessing services related to transportation, social support, and finances. While the pandemic prompted a rapid shift of healthcare services online, including music therapy and social work, questions remain about the quality of this transition, especially for older adults who may not be familiar with or have the resources for telehealth. In this pilot study, investigators are studying music therapy and social work support through telehealth to understand how this approach can impact the well-being, cognition, and service quality for older adults, both with and without dementia. Social workers, who focus on improving well-being and addressing various needs, can leverage the therapeutic relationship built by music therapists to better identify and meet service needs. This pilot study builds on a feasibility project, which indicated that this collaborative framework is acceptable, valuable, and of interest to older adults, facilitating remote community connection. Through this research, investigators aim to evaluate the effectiveness of telehealth services for older adults to inform a future larger trial.

NCT ID: NCT06219005 Not yet recruiting - Nerve Blocks Clinical Trials

Ultrasound-guided Nerve Block Training Model and Evaluation Method

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to assess emergency medicine physician knowledge and technical skill in performance of ultrasound-guided serratus anterior nerve block in a low-fidelity simulation model workshop and to determine the feasibility, acceptability, and usability of the training program. By performing this study, the investigators hope to create a standardized training model which could potentially facilitate POCUS and critical procedural performance and thereby improve patient care.

NCT ID: NCT06218914 Recruiting - Clinical trials for Non-small Cell Lung Cancer

A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation

Start date: February 5, 2024
Phase: Phase 1
Study type: Interventional

Phase I Study of NT-112, an autologous T-cell therapy product genetically engineered to express an HLA-C*08:02-restricted T cell receptor (TCR), targeting KRAS G12D mutant solid tumors.

NCT ID: NCT06218875 Recruiting - Clinical trials for AAA - Abdominal Aortic Aneurysm

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

Start date: May 7, 2024
Phase:
Study type: Observational [Patient Registry]

A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice.

NCT ID: NCT06218823 Enrolling by invitation - Cancer Clinical Trials

Tobacco Treatment Comparison for Cancer Care

Start date: March 1, 2024
Phase: Phase 4
Study type: Interventional

This pilot comparative effectiveness trial will compare two active smoking cessation treatments in terms of effectiveness, equity across patient subpopulations, and efficiency among adult patients diagnosed with cancer within the past 3 years. An enhanced treatment comprising 12 weeks of varenicline treatment and 7 smoking cessation coaching calls with a cancer focus will be compared against an active comparator modeled after standard quitline treatments (2 weeks of nicotine patch therapy with 3 phone coaching calls). Approximately 50 participants will be recruited to generate estimates of the effects, acceptability, costs, and equity of enhanced treatment (vs. standard treatment), with the primary outcome being abstinence from smoking 26 weeks after trying to quit.